Cargando…
Cytokines trigger disruption of endothelium barrier function and p38 MAP kinase activation in BMPR2-silenced human lung microvascular endothelial cells
The bone morphogenetic protein receptor II (BMPRII) signaling pathway is impaired in pulmonary arterial hypertension and mutations in the BMPR2 gene have been observed in both heritable and idiopathic pulmonary arterial hypertension. However, all BMPR2 mutation carriers do not develop pulmonary arte...
Autores principales: | Tielemans, Birger, Stoian, Leanda, Gijsbers, Rik, Michiels, Annelies, Wagenaar, Allard, Farre Marti, Ricard, Belge, Catharina, Delcroix, Marion, Quarck, Rozenn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811766/ https://www.ncbi.nlm.nih.gov/pubmed/31692724 http://dx.doi.org/10.1177/2045894019883607 |
Ejemplares similares
-
Pulmonary arterial hypertension drugs can partially restore altered angiogenic capacities in bmpr2‐silenced human lung microvascular endothelial cells
por: Tielemans, Birger, et al.
Publicado: (2023) -
Incremental Experience in In Vitro Primary Culture of Human Pulmonary Arterial Endothelial Cells Harvested from Swan-Ganz Pulmonary Arterial Catheters
por: Tielemans, Birger, et al.
Publicado: (2021) -
Learning from registries in pulmonary arterial hypertension: pitfalls and recommendations
por: Swinnen, Katleen, et al.
Publicado: (2019) -
COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey
por: Belge, Catharina, et al.
Publicado: (2020) -
BMPR2 spruces up the endothelium in pulmonary hypertension
por: Xiong, Jianhua
Publicado: (2015)